Abstract: While celebrating the 21st year since the very first IEEE 802.11 “legacy” 2 Mbit/s wireless local area network standard, the latest Wi-Fi newborn is today reaching the finish line, topping ...
An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...
At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results